HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Kajiyama Selected Research

Hiroaki Kajiyama Research Topics

Disease

113Neoplasms (Cancer)
05/2022 - 01/2003
51Carcinoma (Carcinomatosis)
03/2022 - 01/2002
34Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 04/2005
25Ovarian Epithelial Carcinoma
01/2022 - 04/2003
19Neoplasm Metastasis (Metastasis)
04/2022 - 07/2004
18Uterine Cervical Neoplasms (Cancer of the Cervix)
11/2021 - 03/2008
14Endometrial Neoplasms (Endometrial Cancer)
11/2021 - 08/2003
10Choriocarcinoma
01/2022 - 08/2003
9Adenocarcinoma
06/2016 - 01/2003
8Ascites
04/2022 - 11/2007
7Rupture
01/2021 - 01/2009
7Endometrioid Carcinoma
01/2014 - 03/2003
6Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2020 - 05/2004
5Inflammation (Inflammations)
12/2022 - 01/2016
5Endometriosis
03/2022 - 01/2006
5Glioblastoma (Glioblastoma Multiforme)
01/2021 - 01/2016
5Residual Neoplasm
05/2016 - 10/2011
4Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
04/2021 - 05/2012
4Lymphatic Metastasis
01/2021 - 01/2005
4Teratoma (Teratoid Tumor)
12/2019 - 05/2012
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
03/2019 - 10/2006
3Pre-Eclampsia (Preeclampsia)
12/2022 - 11/2021
3Postpartum Depression (Post-Natal Depression)
07/2022 - 01/2022
3Infertility (Sterility)
02/2022 - 10/2020
3Melanoma (Melanoma, Malignant)
12/2020 - 02/2010
3Lung Neoplasms (Lung Cancer)
01/2020 - 04/2010
3Carcinogenesis
12/2019 - 03/2005
2Hemolysis
12/2022 - 01/2020
2Pulmonary Hypertension
08/2022 - 01/2021
2Leiomyosarcoma
01/2022 - 08/2013

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2003
14Paclitaxel (Taxol)FDA LinkGeneric
01/2020 - 11/2004
11EnzymesIBA
12/2022 - 04/2003
11PlatinumIBA
03/2022 - 11/2004
11Cisplatin (Platino)FDA LinkGeneric
01/2022 - 03/2006
11Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2010 - 05/2002
10Peptides (Polypeptides)IBA
01/2022 - 03/2003
10Plasma GasesIBA
01/2021 - 06/2016
10Complementary DNA (cDNA)IBA
11/2009 - 04/2003
8MicroRNAs (MicroRNA)IBA
12/2021 - 08/2014
8Indicators and Reagents (Reagents)IBA
01/2021 - 04/2008
8Small Interfering RNA (siRNA)IBA
05/2020 - 01/2007
8Carboplatin (JM8)FDA LinkGeneric
05/2020 - 11/2004
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2018 - 12/2003
8Angiotensin IIIBA
05/2011 - 08/2003
7Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2014
7ParaffinIBA
12/2019 - 01/2004
6leucyl-cystinyl aminopeptidaseIBA
12/2021 - 04/2003
6Cadherins (E-Cadherin)IBA
01/2020 - 05/2003
5Pharmaceutical PreparationsIBA
01/2022 - 02/2010
5Biological ProductsIBA
03/2021 - 08/2004
5Ringer's LactateIBA
03/2021 - 11/2016
5Formaldehyde (Formol)FDA Link
12/2019 - 01/2004
5Capsules (Microcapsules)IBA
03/2019 - 12/2011
5Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019 - 05/2016
5GlypicansIBA
09/2014 - 01/2010
4Hormones (Hormone)IBA
01/2022 - 02/2009
4CytokinesIBA
12/2021 - 01/2016
4DNA (Deoxyribonucleic Acid)IBA
07/2021 - 05/2014
4SolutionsIBA
03/2021 - 11/2016
4Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2010 - 04/2008
4Neprilysin (Neutral Endopeptidase)IBA
03/2005 - 04/2003
4Oxytocin (Pitocin)FDA LinkGeneric
08/2004 - 04/2003
3Glucose (Dextrose)FDA LinkGeneric
12/2022 - 01/2007
3taxaneIBA
03/2022 - 10/2011
3AminopeptidasesIBA
01/2022 - 12/2003
3AcidsIBA
06/2021 - 03/2018
3SpectrinIBA
05/2020 - 01/2012
3ChemokinesIBA
01/2020 - 01/2007
3Messenger RNA (mRNA)IBA
03/2018 - 01/2008
3ubenimexIBA
03/2008 - 05/2007
3Chemokine CXCL12IBA
01/2008 - 07/2004
3Endothelin-1 (Endothelin 1)IBA
03/2005 - 08/2004
3Leucyl Aminopeptidase (Peptidase S)IBA
01/2005 - 08/2003
3Glutamyl Aminopeptidase (Aspartyl Aminopeptidase)IBA
08/2004 - 08/2003
3Peptide Hydrolases (Proteases)FDA Link
08/2004 - 05/2004
2LipopolysaccharidesIBA
12/2022 - 01/2021
2Nitric Oxide (Nitrogen Monoxide)FDA Link
08/2022 - 01/2021
2Tuberculin (PPD)IBA
07/2022 - 01/2022
2IronIBA
05/2022 - 10/2020
2Estrogens (Estrogen)FDA Link
03/2022 - 02/2019
2Phosphotransferases (Kinase)IBA
01/2022 - 03/2020
2Polysaccharides (Glycans)IBA
01/2022 - 07/2021
2Vitamin DFDA LinkGeneric
01/2022 - 01/2021

Therapy/Procedure

33Drug Therapy (Chemotherapy)
04/2022 - 11/2004
26Therapeutics
01/2022 - 04/2005
11Lymph Node Excision (Lymph Node Dissection)
01/2022 - 06/2008
9Hysterectomy
11/2021 - 01/2006
6Adjuvant Chemotherapy
03/2022 - 12/2011
5Radiotherapy
05/2019 - 03/2008
4Salpingo-oophorectomy
05/2022 - 01/2006
4Cystectomy
05/2022 - 04/2013
4Chemoradiotherapy
01/2021 - 05/2016
4Cytoreduction Surgical Procedures
01/2019 - 01/2006
3Aftercare (After-Treatment)
01/2022 - 01/2012
3Neoadjuvant Therapy
01/2022 - 01/2004
3Operative Surgical Procedures
12/2021 - 01/2006
3Trachelectomy
11/2021 - 12/2016
3Immunotherapy
10/2021 - 09/2014
2Cesarean Section (Caesarean Section)
05/2022 - 01/2009